Q4
16.4.2024 14:02:02 CEST | Business Wire | Press release
Q4 Inc. (“Q4” or “the Company”) is redefining investor relations with the IR Ops Platform, delivering a differentiated experience to their clients with seamless workflows and superior insights fueled by secure and private AI. Q4 is the only end-to-end IR Ops Platform designed to empower IR leaders to focus on strategy, building investor relationships, and driving premium valuations.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240416587263/en/
AI Earnings Co-Pilot (Photo: Business Wire)
As the first IR Ops Platform, Q4 is eliminating piecemeal IR solutions by utilizing secure AI to create smart workflows that remove tedious administrative tasks that, if mishandled, could significantly impact Investor Relations Officers (“IROs”) and the organization. By leveraging AI, Q4 ensures accurate and efficient completion of these tasks, equipping IR teams with the capacity to focus on their strategic priorities. Gone are the days of disjointed solutions that lack interoperability, each with their tech that leaves IR leaders with incomplete and disconnected data. With a customizable interface based on the world’s largest set of proprietary investor data, everything an IR team needs is now available on a single platform, maximized for efficiency through AI integration.
“Our extensive experience in IR, including our time as a public company, allows us to fully understand the challenges of investor relations and how to overcome them,” said Darrell Heaps, Founder and CEO of Q4. “The IR Ops Platform was purposefully and securely built as an all-in-one solution with AI at the forefront so IR teams can be more efficient, effective, and ultimately help drive premium valuations for their companies.”
The future of IR is here with AI Earnings Co-Pilot, providing AI accelerated earnings preparation by generating tailored first drafts of earnings scripts from past press releases and earnings results without data privacy or security concerns, saving tens of hours of management time during earnings preparation. IROs can unlock new levels of insights from their IR program with the AI Performance Dashboard experience through key peer insights now aggregated in one centralized location, including succinct earnings transcript summaries, news highlights, and stock movements.
Connected data that unifies piecemeal IR solutions provides leading indicators and insights around potential investors, current shareholders, and circling activists so IR teams can take confident action and connect with quality investors. IROs are able to instantly identify recurring participants across their earnings events with unparalleled access to analytics, unveiling new opportunities for engagement and targeted outreach. With simplified earnings lifecycle management, website updates are published 16 times faster than competitors and events boast a 99% platform reliability rate, creating a trusted and intelligent digital destination for investors.
“By creating a single, powerful platform for investor relations, we are increasing the value we provide to our issuer and agency clients, enabling them to successfully implement their IR strategies with unprecedented speed and precision,” remarked Heaps. “We’re proud to be at the forefront of innovation in the IR space and we’re committed to helping IROs thrive.”
As of April 16, 2024, Q4’s IR Ops Platform is available to all Q4 customers and prospects. To learn more or request a demo, please visit www.q4inc.com.
About Q4 Inc.
Q4 Inc. is the first IR Ops Platform with the world’s largest set of proprietary investor data, purpose-built to remove obstacles between public companies and their investors. Q4 gives investor relations leaders and their teams the tools to attract, manage, and understand investors — all in one place. The AI-enabled Q4 IR Ops Platform boasts a simple yet powerful IR website management system, frictionless events software, a robust analytics engine, a streamlined investor CRM, and shareholder intelligence with enhanced metrics to elevate investor targeting strategies. Q4 delivers the data, insights, and workflows that give IR teams the power to focus on what really matters: strategy, relationships, and driving premium valuations for their companies.
The company is a trusted partner to more than 2,600 public companies globally, including many of the most respected brands in the world, and maintains an award winning culture where team members grow and thrive.
Q4 is headquartered in Toronto, with offices in New York and London. Learn more at www.q4inc.com.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20240416587263/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
NetJets Becomes Official Private Aviation Provider of the Hahnenkamm Races in Kitzbühel20.11.2026 18:45:00 CET | Press release
The Partnership brings together two brands committed to excellence, precision and exceptional experiences NetJets, the global leader in private aviation, is delighted to announce its newest partnership with the Hahnenkamm Races in Kitzbühel, Austria, becoming the event's Official Private Aviation Provider. The Hahnenkamm Races are among the most prestigious and celebrated events in world alpine skiing. They attract athletes, business leaders, international guests and winter sports enthusiasts from around the world. Through this partnership, NetJets and the Hahnenkamm Races are aligning two brands renowned for excellence, precision and world-class experiences. The partnership is an exciting addition to NetJets' growing portfolio of premium lifestyle and sporting partnerships, offering Owners unique opportunities to access one of Europe's most iconic winter sporting events. Alongside premium hospitality and unforgettable behind-the-scenes experiences, the collaboration will help create e
Frontgrade Technologies Help Power Critical Computing and Electronics Aboard NASA’s Roman Space Telescope20.11.2026 18:40:00 CET | Press release
Frontgrade processors and radiation-hardened microelectronics support critical spacecraft and instrument functions on NASA’s flagship astrophysics mission Frontgrade today announced that technologies from across its space electronics portfolio are supporting multiple mission-critical systems aboard NASA’s Nancy Grace Roman Space Telescope, which successfully launched on August 30, 2026. Roman is NASA’s flagship astrophysics observatory designed to investigate dark energy, discover exoplanets and explore the evolution of the universe. Its onboard electronics include radiation-hardened processors and microelectronics, providing critical processing, communications, power-management and control functions across the spacecraft. At the centre of Roman’s computing architecture are Frontgrade Gaisler’s GR740 and GR712RC processors. The GR740 radiation-hardened quad-core LEON4FT processor serves as the computing engine for the Wildcat Processor Card, used in the spacecraft’s primary and redunda
Inside Moutai House Singapore: Beyond Baijiu, A Cultural Encounter20.11.2026 16:05:00 CET | Press release
On November 13, Moutai House officially opened at Fullerton Waterboat House in Singapore. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261120301288/en/ On November 13, Moutai House officially opened at Fullerton Waterboat House in Singapore. As the world’s first Moutai brand experience space built under its new SI standards, this three-storey venue brings together cultural exhibitions, baijiu tasting, distinctive dining and creative cocktails. Using Moutai as a bridge, it creates new opportunities for Chinese baijiu culture to blend with and draw inspiration from Singapore’s diverse lifestyle and cultural scene. As early as 1954, Guizhou Moutai arrived in Singapore via the Singapore River, marking its first entry into Southeast Asia, right across from Fullerton Waterboat House. 72 years later, Moutai House has found its home along the same riverbank, transforming a historic arrival into a lasting presence and turning a con
ViTAA Medical and The Society for Vascular Surgery Announce Strategic Partnership20.11.2026 15:00:00 CET | Press release
ViTAA Medical to Become Key SVS AI Partner, Advancing AI Education and Responsible Adoption in Vascular Care ViTAA Medical Solutions Inc. (ViTAA) today announced a strategic partnership with The Society for Vascular Surgery (SVS) to advance evidence, education, and the responsible adoption of quantitative imaging and artificial intelligence in vascular care. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261120954362/en/ The partnership will support evidence building, best practices, educational resources for SVS members, physicians and trainees on AI validation, interpretation, and clinical limitations. The relationship has the potential to pave the way for additional AI tools and resources for SVS members through the Society in the future. The partnership creates a framework for the organizations to lead AI-enabled research opportunities involving imaging and clinical outcomes. Mitchel Benovoy, PhD, Chief Executive Officer
Epitech Group and Horus Pharma sign a global licensing agreement to develop adelmidrol in eye health20.11.2026 14:39:00 CET | Press release
Epitech Group S.p.A., an Italian biopharmaceutical firm specializing in neuro-inflammation, and Horus Pharma, a French laboratory specializing in ophthalmology, announce a global licensing agreement for adelmidrol, a molecule belonging to the ALIAmide family, developed by Epitech Group. This agreement grants Horus Pharma exclusive rights to develop and market adelmidrol for human ophthalmology and periocular dermatology applications. It aims to explore new approaches to address unmet medical needs in eye health. A combination of complementary scientific expertise Epitech Group has been studying ALIAmides and their role in physiological regulatory mechanisms for over 30 years, building on the research of Rita Levi-Montalcini, the 1986 Nobel Prize in Medicine laureate who first identified the ALIA mechanism. Horus Pharma, for its part, contributes over 20 years of ophthalmology expertise, strong R&D capabilities, and its international presence. Against the backdrop of an aging population
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
